Published in Arthritis Rheum on September 01, 1988
A human fetal monoclonal DNA-binding antibody shares idiotypes with fetal and adult murine monoclonal DNA-binding antibodies. Immunology (1990) 0.97
Serological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype. J Clin Invest (1994) 0.89
Autoantibodies to cerebroside sulphate (sulphatide) in leprosy. Clin Exp Immunol (1994) 0.82
Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseases. Clin Exp Immunol (1991) 0.81
Relation between lymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses. Clin Exp Immunol (1989) 0.81
Expression of public idiotypes in patients with Lyme arthritis. Ann Rheum Dis (1993) 0.80
Serological abnormalities, including common idiotype PR4, in families with rheumatoid arthritis. Ann Rheum Dis (1989) 0.78
Expression of a common idiotype PR4 in the sera of patients with leprosy. Clin Exp Immunol (1991) 0.76
Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis (1990) 0.76
Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ (1976) 12.01
Real-time RT-PCR normalisation; strategies and considerations. Genes Immun (2005) 10.93
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
A simple method for detecting antibodies to rubella. Br J Exp Pathol (1975) 5.80
Microplate enzyme-linked immunosorbent assay for chagas' disease. Lancet (1975) 5.70
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94
Moving to research partnerships in developing countries. BMJ (2000) 4.70
Immunofluorescence method suitable for large-scale application to malaria. Bull World Health Organ (1971) 4.46
Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol (1993) 4.42
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet (2004) 4.25
Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol (1978) 3.93
Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ (1990) 3.84
Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis (2001) 3.75
A microplate enzyme-immunoassay for toxoplasma antibody. J Clin Pathol (1976) 3.64
Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination. Br J Exp Pathol (1976) 3.39
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol (1979) 3.20
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol (1995) 2.69
A microplate method of enzyme-linked immunosorbent assay and its application to malaria. Bull World Health Organ (1974) 2.66
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci (2001) 2.48
Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med (1976) 2.45
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis (2002) 2.44
The communication of ELISA data from laboratory to clinician. J Immunoassay (1980) 2.39
Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis (1993) 2.36
Is there an acute-phase response in steady-state sickle cell disease? Lancet (1993) 2.35
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum (2000) 2.28
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Immunosuppression during trypanosomiasis. Br J Exp Pathol (1972) 2.13
Mixed connective tissue disease--goodbye to all that. Br J Rheumatol (1992) 2.11
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect (2014) 2.06
Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice. J Exp Med (1979) 2.03
Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet (1997) 1.99
Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature (1980) 1.97
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest (1978) 1.90
Human and bovine tuberculosis in the Monze District of Zambia--a cross-sectional study. Br Vet J (1996) 1.88
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J (2001) 1.83
The detection of viruses by enzyme-linked immunosorbent assay (ELISA). J Gen Virol (1976) 1.82
Malaria, anaemia and pregnancy. Ann Trop Med Parasitol (1969) 1.81
Splenomegaly in New Guinea. Bull World Health Organ (1967) 1.81
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
New serological test for malaria antibodies. Br Med J (1975) 1.74
Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax (2009) 1.74
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
The spectrum of ocular toxocariasis. Eye (Lond) (1993) 1.73
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS (1997) 1.73
A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med (1982) 1.68
Heterogeneity of human serum amyloid A proteins. J Exp Med (1980) 1.68
Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health (1997) 1.65
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
Factor-VIII-related antigen: measurement by enzyme immunoassay. Br Med J (1976) 1.64
Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int (1995) 1.63
Associates of health status in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.62
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2007) 1.62
A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.60
Studies on immunoglobulins of Nigerians. I. The immunoglobulin levels of a Nigerian population. J Trop Med Hyg (1966) 1.59
Treatment adherence and clinical outcome in systemic lupus erythematosus. Rheumatology (Oxford) (2007) 1.59
Mycobacterial infections and AIDS. Br Med Bull (1988) 1.59
Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest (1985) 1.59
The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS (1993) 1.58
C57BL/10/CR mice: nonresponders to activation by the lipid a moiety of bacterial lipopolysaccharide. J Immunol (1978) 1.58
In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob Agents Chemother (1990) 1.57
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J (2010) 1.57
Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. Lancet (1975) 1.56
The epidemiologic interpretation of serologic data in malaria. Am J Trop Med Hyg (1972) 1.56
Serological malaria surveys in Nigeria. Bull World Health Organ (1968) 1.55
Historical declines in tuberculosis: nature, nurture and the biosocial model. Int J Tuberc Lung Dis (2001) 1.54
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Tuberculosis--an epidemic of injustice. J R Coll Physicians Lond (1998) 1.52
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol (1995) 1.49
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy (2001) 1.49
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol (1995) 1.49
Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus patients. Rheumatology (Oxford) (2008) 1.48
Sjögren's syndrome: association with type-1 diabetes mellitus. Br J Rheumatol (1989) 1.48